What does New Era Alkaloids And Exports Ltd manufacture?

New Era Alkaloids And Exports Ltd manufactures basic chemicals and alkaloids, including Active Pharmaceutical Ingredients (APIs). Based in Ratlam, Madhya Pradesh, the company is part of India's pharmaceutical chemical manufacturing ecosystem serving both domestic formulations manufacturers and export markets.

Is New Era Alkaloids And Exports Ltd listed on any stock exchange?

No, the company is unlisted. Its shares are traded only through the Indian unlisted market at approximately ₹10 per share.

Where is New Era Alkaloids And Exports Ltd located?

New Era Alkaloids And Exports Ltd is headquartered in Ratlam, Madhya Pradesh, a key pharmaceutical and chemical manufacturing cluster in central India.

What are alkaloids used for in pharmaceuticals?

Alkaloids are a class of naturally occurring nitrogenous compounds used extensively in pharmaceuticals. Common examples include morphine (pain relief), codeine (cough suppressant), quinine (antimalarial), caffeine, and atropine. These form the basis of numerous essential medicines.

What regulatory approvals does an alkaloid manufacturer need in India?

Alkaloid manufacturers in India require approval from the Narcotics Control Bureau (NCB) under the NDPS Act for controlled substances, Drug Manufacturing Licences from State Drug Authorities, and compliance with Factories Act and Pollution Control Board norms. Export-oriented units additionally need DGFT and country-specific import clearances.

What is the lot size for New Era Alkaloids And Exports unlisted shares?

The lot size is 1 share, allowing investors to purchase in any quantity through unlisted share intermediaries.

How do I buy New Era Alkaloids and Exports unlisted shares here?

Raise an enquiry on any company with the quantity you want. Our desk sources the shares and comes back with a firm price and allocation. You accept the allocation, transfer the funds to the desk's published bank account, and once we verify payment the shares are transferred into your demat.

Who am I actually transacting with?

You transact with the desk, not with an anonymous counterparty. When you buy, you buy from the desk; when you sell, you sell to the desk. Shares always route through the desk's own demat account, so there's one accountable party for the whole trade.

How do I pay, and is there a payment gateway?

Payment is by direct bank transfer to Prospire Network Private Limited's published account (CIN U82300UP2025PTC233622), shown to you in-app at the payment step. There is no card gateway and no escrow. Never pay to a personal account or to any account shared over phone, WhatsApp or email — even if the person claims to be from our team.

How long does settlement take?

After you accept an allocation, you have a short window to pay (typically 2 days). Once payment is verified, shares are usually credited to your demat within 2–3 business days, subject to depository timelines and any company-level restrictions. Timeframes are typical, not guaranteed.

There are no separate platform fee lines and no GST on the transfer — the desk's margin is built into the buy/sell price you're quoted. The only statutory add-on on a purchase is stamp duty on the consideration, shown transparently in your cost breakdown.

Is there a minimum ticket size for New Era Alkaloids and Exports?

Minimums vary by company and depend on the lot the desk can source. Raise an enquiry and the desk will confirm the available quantity and the minimum for that name.

What KYC do I need, and do I need a demat account?

You'll share your demat details when you enquire so we can settle directly. Full KYC — PAN and a client-master / demat statement — is required before the transfer step, when shares actually change hands. Yes, you need an active demat account to hold unlisted shares.

Are there lock-ins on unlisted or pre-IPO shares?

Some shares carry statutory or company-imposed lock-ins — for example, a post-listing lock-in on pre-IPO stock — and transfers can be subject to the company's articles or approvals. Where a lock-in applies, we'll flag it before you commit.

How do I sell New Era Alkaloids and Exports shares I already hold?

Raise a sell enquiry with the company, quantity and your target price. The desk confirms a buying price, you transfer your shares into the desk's demat, and once the credit is verified we pay you out by bank transfer to your registered account. The desk never pays out before your shares are received.

Unlisted shares are illiquid, may be hard or impossible to sell, and are not covered by exchange settlement guarantees or investor-protection funds. Pricing is indicative, not live. Read the full Risk Disclosure before you enquire, and invest only what you can afford to lock away.

New Era Alkaloids and Exports Unlisted Share Price | Buy New Era Alkaloids and Exports Pre-IPO Shares — wisefolio

Investment Thesis

New Era Alkaloids And Exports Ltd is a specialised pharmaceutical chemicals company in Ratlam, MP, operating in the technically demanding alkaloids and API segment since 1994. While the sector offers strong structural demand tailwinds driven by India's pharma export growth, the company's small scale, lack of public ISIN, and the complex regulatory environment for alkaloid manufacturers demand thorough due diligence. The website neweraltd.com provides a starting point for further research.

Pros

Ratlam, Madhya Pradesh is a well-established pharmaceutical and chemical manufacturing hub in central India, providing access to skilled labour and API supply chains
Alkaloid manufacturing is a highly specialised niche with significant barriers to entry including complex chemistry, regulatory compliance, and technical know-how
Active Pharmaceutical Ingredients (APIs) are in structurally growing demand driven by India's generic drug export leadership and domestic formulation industry
India is the world's largest supplier of generic medicines; API manufacturers in India benefit from strong domestic and export demand
Opium alkaloids (codeine, morphine derivatives) are regulated high-value commodities with government licensing providing a natural barrier to competition

Cons

ISIN not publicly confirmed, limiting regulatory verifiability for potential investors
Manufacturing of alkaloids including potentially controlled substances (narcotics alkaloids) is subject to strict NDPS Act and Narcotics Control Bureau oversight — any compliance lapse carries severe consequences
Share price of ₹10 suggests limited market participant interest or early-stage unlisted trading
Small-scale manufacturer competing with large established API companies like Divi's Laboratories, Alchem, and Macfarlan Smith
Export sales of alkaloids are subject to international narcotics control treaties and buyer country import regulations, creating additional compliance burden

Business Segments

Alkaloid Manufacturing

Production of pharmaceutical-grade alkaloids including opium-derived and plant-based alkaloids used as APIs in formulations

Basic Chemicals

Manufacture of basic chemical intermediates for pharmaceutical and industrial use

Exports

Export of alkaloids and chemical products to regulated international markets including Europe and the Americas

Revenue Model

New Era Alkaloids And Exports Ltd generates revenue through B2B sales of manufactured alkaloids and basic chemicals to pharmaceutical formulations companies in India and abroad. Export revenue is subject to international narcotics control licensing. Pricing is typically contract-based with pharmaceutical manufacturers.

Detailed Analysis

Growth outlookExpansion plans, industry tailwinds & headwinds11

Growth Plans

India's dominance in global generic drug supply driving strong demand for domestic API manufacturers

Government of India's Production Linked Incentive (PLI) scheme for APIs encouraging domestic production capacity

Growing demand for alkaloid-based APIs in pain management, cough formulations, and neurological medicines globally

China+1 sourcing strategy by global pharma companies creating new export opportunities for Indian API manufacturers

Recent Developments

Unlisted share market activity

Shares of New Era Alkaloids And Exports Ltd are available in the Indian unlisted share market at approximately ₹10 per share.

Comparable Companies

CompanyTypeTickerMkt Cap

Divi's LaboratoriesListedDIVISLAB~₹1,20,000 Cr

Indswift LaboratoriesListedINDSWFTLAB~₹600 Cr

Divi's LaboratoriesListed

DIVISLAB · ~₹1,20,000 Cr

Indswift LaboratoriesListed

INDSWFTLAB · ~₹600 Cr

Frequently Asked Questions

About New Era Alkaloids and Exports

New Era Alkaloids And Exports Ltd is a specialised pharmaceutical manufacturer incorporated on February 9, 1994 in Ratlam, Madhya Pradesh. With CIN L02423MP1994PLC008116, the company operates in the highly regulated segment of alkaloid manufacturing and pharmaceutical exports. Ratlam in Madhya Pradesh is a significant hub for opium alkaloid processing in India, where poppy cultivation is regulated and licensed by the Central Government's Narcotics Commissioner. India is the world's largest legal producer of opium for pharmaceutical purposes under international treaties, and companies like New Era Alkaloids play an important role in this regulated supply chain. The company is engaged in manufacturing and exporting alkaloids -- chemical compounds derived from plant sources including opium poppy -- which serve as critical raw materials for pharmaceutical formulations. Key alkaloids produced by such companies include morphine, codeine, thebaine, and their derivatives, which are used in pain management medications, cough suppressants, and other pharmaceutical applications globally. New Era Alkaloids operates from its registered address at 21 Freeganj, Ratlam, Madhya Pradesh 457001. With an authorised share capital of INR 3.50 crore and paid-up capital of INR 3.28 crore, it is a small but specialised producer operating within India's strictly regulated narcotics and pharmaceutical export framework. The company has five directors including Ravi Kamra and Satyawati Parashar, and maintains active status with the Registrar of Companies, Madhya Pradesh. Indian alkaloid manufacturers like New Era Alkaloids benefit from the country's government-controlled poppy cultivation framework, which provides regulated access to raw materials while ensuring international compliance with the International Narcotics Control Board (INCB) treaties.

Key Milestones

1994: Incorporated in Madhya Pradesh under CIN L02423MP1994PLC008116 as a pharmaceutical chemicals manufacturer

Common questions about unlisted shares

How do I buy New Era Alkaloids and Exports unlisted shares here?
Raise an enquiry on any company with the quantity you want. Our desk sources the shares and comes back with a firm price and allocation. You accept the allocation, transfer the funds to the desk's published bank account, and once we verify payment the shares are transferred into your demat.
Who am I actually transacting with?
You transact with the desk, not with an anonymous counterparty. When you buy, you buy from the desk; when you sell, you sell to the desk. Shares always route through the desk's own demat account, so there's one accountable party for the whole trade.
How do I pay, and is there a payment gateway?

New Era Alkaloids And Exports Ltd

How settlement works

Get price alerts for New Era Alkaloids And Exports Ltd

Discuss New Era Alkaloids and Exports

Similar companies

Other ways to invest